NCT02541786View on ClinicalTrials.gov

Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

dexlansoprazole based triple therapy

dexlansoprazole MR 60 mg once daily+clarithromycin 500 mg twice daily+ amoxicillin 1 g twice daily for 7 days

DRUG

rabeprazole-based triple therapy

rabeprazole 20 mg twice daily + clarithromycin 500 mg twice daily + amoxicillin 1 g twice daily for 7 days

Trial Locations (2)

807

Kaohsiung Medical University Hospital, Kaohsiung City

813

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University

OTHER

NCT02541786 - Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection | Biotech Hunter | Biotech Hunter